Dermatomyositis (DM) is a disease of unknown etiology characterized by typical skin lesions and bilateral, progressive, symmetrical proximal muscle weakness caused by perivascular non-supportive inflammatory processes [1].Because of its low incidence, there are few reports on anesthetic management of patients with DM during general anesthesia. Moreover, there are contradictory reports on onset and recovery from neuromuscular blockade with various muscle relaxants in patients with DM.Anesthetic management in patients with DM might be challenging, it depends on disease severity, presence of coexisting diseases, and abnormal response to muscle relaxants.Here, we report a case of delayed onset of neuromuscular blockade and prolonged recovery after administration of 0.6 mg/kg rocuronium, followed by normal response to reversal after administration of pyridostigmine in a patient with DM.
CASE REPORTA 50-year-old woman (height 162 cm, weight 49 kg) was Dermatomyositis is an idiopathic inflammatory myopathy characterized by skin changes and muscle weakness. Depending on the involvement of various muscles, dermatomyositis can cause aspiration pneumonia, ventilatory impairment, and heart failure. Several reports have documented normal or prolonged neuromuscular blockade following administration of different non-depolarizing neuromuscular blockers in patients with dermatomyositis. We observed delayed onset of blockade and prolonged recovery following administration of 0.6 mg/kg rocuronium in a patient with dermatomyositis. However, when the train-of-four ratio reached 0.3, the patient was administered pyridostigmine and glycopyrrolate, which led to normal response to reversal of rocuronium. The patient was extubated without respiratory complications. The outcomes of this case indicate that response to the usual dosage of muscle relaxants in patients with dermatomyositis might be different from that in patients without this condition. Anesthesiologists should pay attention to preoperative cardiorespiratory evaluation and intraoperative neuromuscular monitoring.